Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD

被引:70
作者
Fujii, Y
Okuda, D
Fujimoto, Z
Horii, K
Morita, T
Mizuno, H
机构
[1] Natl Inst Agrobiol Sci, Dept Biochem, Tsukuba, Ibaraki 3058602, Japan
[2] Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan
关键词
disintegrin; RGD sequence; integrin; snake venom; X-ray crystallography;
D O I
10.1016/S0022-2836(03)00991-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Disintegrins are a family of small proteins containing an Arg-Gly-Asp (RGD) sequence motif that binds specifically to integrin receptors. Since the integrin is known to serve as the final common pathway leading to aggregation via formation of platelet -platelet bridges, disintegrins act as fibrinogen receptor antagonists. Here, we report the first crystal structure of a disintegrin, trimestatin, found in snake venom. The structure of trimestatin at 1.7 Angstrom resolution reveals that a number of turns and loops form a rigid core stabilized by six disulfide bonds. Electron densities of the RGD sequence are visible clearly at the tip of a hairpin loop, in such a manner that the Arg and Asp side-chains point in opposite directions. A docking model using the crystal structure of integrin alphaVbeta3 suggests that the Arg binds to the propeller domain, and Asp to the betaA domain. This model indicates that the C-terminal region is another potential binding site with integrin receptors. In addition to the RGD sequence, the structural evidence of a C-terminal region (Arg66, Trp67 and Asn68) important for disintegrin activity allows understanding of the high affinity and selectiveness of snake venom disintegrin for integrin receptors. The crystal structure of trimestatin should provide a useful framework for designing and developing more effective drugs for controlling platelet aggregation and anti-angiogenesis cancer. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1115 / 1122
页数:8
相关论文
共 39 条
[31]   3-DIMENSIONAL STRUCTURE OF ECHISTATIN, THE SMALLEST ACTIVE RGD PROTEIN [J].
SAUDEK, V ;
ATKINSON, RA ;
PELTON, JT .
BIOCHEMISTRY, 1991, 30 (30) :7369-7372
[32]  
SCARBOROUGH RM, 1991, J BIOL CHEM, V266, P9359
[33]  
SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1058
[34]   THE NUCLEAR-MAGNETIC-RESONANCE SOLUTION STRUCTURE OF FLAVORIDIN, AN ANTAGONIST OF THE PLATELET GP-IIB-IIIA RECEPTOR [J].
SENN, H ;
KLAUS, W .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (03) :907-925
[35]  
Smith KJ, 1996, INT J PEPT PROT RES, V48, P220
[36]   AN ECHISTATIN C-TERMINAL PEPTIDE ACTIVATES GPIIBIIIA BINDING TO FIBRINOGEN, FIBRONECTIN, VITRONECTIN AND COLLAGEN TYPE-I AND TYPE-IV [J].
WRIGHT, PS ;
SAUDEK, V ;
OWEN, TJ ;
HARBESON, SL ;
BITONTI, AJ .
BIOCHEMICAL JOURNAL, 1993, 293 :263-267
[37]   Crystal structure of the extracellular segment of integrin αVβ3 [J].
Xiong, JP ;
Stehle, T ;
Diefenbach, B ;
Zhang, RG ;
Dunker, R ;
Scott, DL ;
Joachimiak, A ;
Goodman, SL ;
Arnaout, MA .
SCIENCE, 2001, 294 (5541) :339-345
[38]   Crystal structure of the extracellular segment of integrin αVβ3 in complex with an Arg-Gly-Asp ligand [J].
Xiong, JP ;
Stehle, T ;
Zhang, RG ;
Joachimiak, A ;
Frech, M ;
Goodman, SL ;
Arnaout, MA .
SCIENCE, 2002, 296 (5565) :151-155
[39]   Molecular cloning and functional expression of contortrostatin, a homodimeric disintegrin from southern copperhead snake venom [J].
Zhou, Q ;
Hu, PS ;
Ritter, MR ;
Swenson, SD ;
Argounova, S ;
Epstein, AL ;
Markland, FS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 375 (02) :278-288